LLY: Potential Bounce Play with 20–30% UpsideLooking for a stock that had strong momentum before but has slowed down over the past year? One that’s now trading near the bottom of its consolidation range, with about a 30% drop from recent highs? LLY fits that description pretty well.
Based on its pattern, it looks like there’s a good chance it
Key facts today
Eli Lilly is investing billions in U.S. manufacturing and research facilities, partnering with major pharmaceutical firms to boost domestic production.
0.20 USD
9.41 B USD
40.01 B USD
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFVYP1
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
LLY is now interested?Interested Chart??
Eli Lilly (LLY) is one of the Big Pharma stocks with strong fundamentals, and it's a growth stock too. So, is it a good time to accumulate now??
After LLY's price kept dropping for a while, it now seems to be forming a structure where it's not falling below $700. Looks like it
LLY Daily: Navigating Key Levels - Two Strategic OpportunitiesOVERVIEW:
LLY has recently undergone a significant correction from its highs, finding strong demand at a crucial support zone. Price action now presents two distinct, high-probability long entry scenarios based on the stock's interaction with key horizontal levels. My analysis outlines potential ent
Eli Lilly Stock Down 10.9% Over Past YearTop or Consolidation? Here's My Take...
It's not crystal clear — I can see the case for both. But after years of chart-watching, this doesn't quite look like a top to me:
• Lacks symmetry
• Had chances to break down, but no real follow-through
🧭 Where are we headed?
I think pressure remains, and we
Eli Lillly $LLYNYSE:LLY – Long Setup Ahead of June FOMC
Eli Lilly remains fundamentally strong, with robust growth in revenue (+45% YoY), driven by weight-loss and diabetes drugs like Mounjaro and Zepbound. Despite this, the stock saw a recent pullback after a lowered FY25 profit outlook.
Technical View:
LLY is
LLY - Stock held $720 support next level at $760LLY - Stock back to bouncing off $720 support level on the weekly time frame. Needs to break and hold $760 resistance level for a move towards $800 . Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial. calls above $760 look good for a move towards $800
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
ELI LILLY 21/43Yield to maturity
7.64%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.32%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.16%
Maturity date
Sep 15, 2060
US532457BU1
ELI LILLY 19/59Yield to maturity
6.29%
Maturity date
Mar 15, 2059
US532457BT4
ELI LILLY 19/49Yield to maturity
6.24%
Maturity date
Mar 15, 2049
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.21%
Maturity date
Mar 1, 2045
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.15%
Maturity date
May 15, 2047
US532457BS6
ELI LILLY 19/39Yield to maturity
6.10%
Maturity date
Mar 15, 2039
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
5.86%
Maturity date
Feb 27, 2063
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
5.86%
Maturity date
Feb 9, 2064
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053Yield to maturity
5.83%
Maturity date
Feb 27, 2053
See all LLYD bonds
Curated watchlists where LLYD is featured.